About Kriya Therapeutics
Kriya Therapeutics is a private company based in Morrisville, North Carolina. It has reported $870,251,801 raised in four offerings on Form D since May 2020. Its chief executive is Shankar Ramaswamy.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 2025 | Aug 15, 2025amended Sep 10, 2025 | $320,822,412fully sold | 10 | $32.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 10, 2022 | May 24, 2022amended Jul 27, 2023 | $361,794,505of $432.0M target | 29 | $12.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 30, 2021 | Jul 14, 2021 | $99,999,999fully sold | 36 | $2.7M | EquityRule 506(b) | Form D ↗ |
| May 4, 2020 | May 19, 2020amended Aug 18, 2020 | $87,634,885of $87.6M target | 21 | $4.1M | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Total, four offerings | $870,251,801 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kriya Therapeutics's Form D filed Sep 10, 2025.
NV
Neelaksh Varshney
Director
MS
Michele Stone
Executive officer
IO
Ilan Oren
Director
SR
Saira Ramasastry
Director
RG
Ryan Gallagher
Director
KM
Keith Manchester
Director
KE
Katherine Eade
Executive officer
JM
James Momtazee
Director
AR
Akshay Rai
Director
SR
Shankar Ramaswamy
Chief Executive Officer and director
CH
Curt Herberts
Executive officer
BP
Britt Petty
Executive officer
RJ
Roger Jeffs
Director
BF
Brian Furmanski
Executive officer
TG
Trit Garg
Director
Earlier filings also listed Dana Johnson (executive officer, last listed Jul 2023), Daniel Chen (executive officer, last listed Jul 2021) and C.r. Sincock (director, last listed Jul 2021).